Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study.
暂无分享，去创建一个
M. Kozal | P. Cahn | J. Aberg | J. Molina | G. Pialoux | B. Grinsztejn | R. Diaz | J. Lalezari | A. Castagna | S. Moreno | Shiven B Chabria | M. Thompson | C. Llamoso | M. Lataillade | Princy N. Kumar | G. Latiff | A. Pierce | Peter Ackerman | M. Gartland | Edwin De Jesus | Marcia Wang